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Medication non-adherence is a significant clinical
challenge that adversely affects psychosocial factors,
costs, and outcomes that are shared by patients, fam-
ily members, providers, healthcare systems, payers,
and society. Patient-centered care (i.e., involving
patients and their families in planning their health
care) is increasingly emphasized as a promising ap-
proach for improving medication adherence, but clini-
cian education around what this might look like in a
busy primary care environment is lacking. We use a
case study to demonstrate key skills such as motiva-
tional interviewing, counseling, and shared decision-
making for clinicians interested in providing patient-
centered care in efforts to improve medication adher-
ence. Such patient-centered approaches hold consid-
erable promise for addressing the high rates of non-
adherence to medications for chronic conditions.
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A dherence to medications is often suboptimal—up to50 % of patients do not take their prescribed medication
as recommended.1–4 Medication non-adherence is associated
with adverse health outcomes as well as negative social and
economic consequences.5–7 The problem of medication non-
adherence is often multifaceted and multifactorial; in general,
most conceptual models of medication non-adherence take an
ecological perspective, and include patient factors (e.g., liter-
acy, cognitive function), provider factors (e.g., complex regi-
mens), social/community factors (e.g., access to providers and
pharmacy), health care factors (e.g., interaction with health-
care system, trust, prior authorization, fragmentation), and
policy implications (e.g., coverage of medication).8–10 Thus,
to be effective, interventions designed to improve appropriate
medication use must adopt a comprehensive approach, often
combining numerous proven strategies. Several evidence
reviews have identified interventions with modest effects in
promoting both overall and condition-specific medication ad-
herence.11–16 Given the complex, multifactorial cause of med-
ication non-adherence, interventions can be similarly multi-
factorial and multi-level. In this paper we focus on the
physician-patient level to furnish providers with a guide to
applying adherence research in the clinical encounter.
Evidence increasingly demonstrates that adopting a person-
centered approach for medication use that incorporates patient
beliefs, preferences, goals, and barriers to medication-taking
(e.g., cost, technological ability, concerns about medication
prescribing and use) leads to better clinical outcomes.17,18
Clinicians are in a key position to elicit this information from
patients and to incorporate it into medication-related decisions,
thereby improvingmedication adherence rates. Person-centered
care focuses on providing patients with greater choice, recog-
nizing their roles as consumers of health care who know best
their own beliefs and preferences. This care is meant to encour-
age value concordance—in this case, the match between the
treatment that is selected and the treatment that is most desirable
to the patient in terms of timing, duration of a therapy, or
potential physical, emotional, and social effects.19 As payment
and delivery system models evolve to hold healthcare organ-
izations and clinicians accountable for poor patient outcomes
and downstream costs (e.g., via bundled payments and account-
able care organizations), there is an increasing business case and
need to identify methods to improve medication adherence by
including patient-centered care.
We seek to provide methods and tools that healthcare pro-
viders might use to advance communication with their patients
and ultimately to improve appropriate medication use. To
accomplish this, we explore how healthcare providers can
partner with patients to improve adherence by using person-
centered approaches—defined as those that consider the
whole person20—including motivational interviewing,Published online September 6, 2016
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counseling, and shared decision-making. Using a case study,
this paper demonstrates how these concepts can be
operationalized.
CLINICAL SCENARIO 1. INTRODUCTION
Mrs. K. is a 55-year-old African-American woman with hy-
pertension and diabetes who is visiting you (her provider) with
a chief complaint of back pain. In addition, she reports not
sleeping well and describes symptoms of depression. Her self-
reported blood pressure values are consistently in the range of
142–155/83–91 mm Hg. Beyond treating her pain, you want
to evaluate whether you should prescribe an anti-hypertensive
medication. You also appreciate the impact of the depressive
symptoms and lack of restful sleep as possible contributors to
the patient presentation. Although she did not bring them to
her appointment, Mrs. K. has been prescribed twomedications
for diabetes and is concerned about the cost. She voluntarily
tells you that she takes her medicines exactly as instructed. She
expresses hesitancy to take another medication because of her
budget constraints. She is currently out of work, and cost
issues are a concern. Taking her financial concerns into con-
sideration, you provide guidance about her back pain, and ask
her to return in 4 weeks and bring her medications.
PERSON-CENTERED CARE
Previous studies have found that patient engagement, involve-
ment, and satisfaction with health care are improved with more
informative communication.21,22 These issues often lie below
the surface of healthcare encounters and treatment decisions
by providers. However, merely informing patients of their
options and providing evidence on risks and benefits does
not necessarily lead to quality decisions.23 Providers must also
set and manage expectations for the treatment plan and clarify
objectives of therapy so that patients can gauge their ability to
attain therapeutic goals. This dialogue can be limited due to
time constraints during the clinical encounter; however, recent
research indicates that such dialogue can often be completed
efficiently and result in positive outcomes.7 Another barrier to
dialogue may be a deficiency in medical training in patient-
centered care or appropriate medication adherence assessment
and implementation, or both.
To address the latter, there is a growing shift in medical
education toward developing person-centered skill sets that
help providers understand and manage varying levels of pa-
tient interest, knowledge, and health literacy.24,25 Once the
provider has confirmed that patients understand their disease
and have been offered options that they understand, the pro-
vider can help ensure that the patients’ decisions reflect their
goals and preferences. A key step is assessing whether the
facts were received and understood. Decision quality reflects
the extent to which patients are informed and understand their
options, and importantly, that decisions made reflect their
goals and preferences.26 With this transition in medical edu-
cation, providers will likely benefit from learning new skills to
improve communication with patients during visits. There are
also resources available to support practicing physicians, such
as ManagingYourMeds (available from http://managingyour-
meds.org), which lists a number of promising medication
adherence practices. In addition, below we highlight simple
techniques for evaluating medication use and improving
shared decision-making and counseling in the context of med-
ication adherence.
EVALUATING APPROPRIATE MEDICATION USE
Providers and patients tend to overestimate medication adher-
ence.27 Even if a patient appears to be responding to therapy,
adherence may occur only immediately before a visit. Clini-
cians tend to assume that their patients are adhering to medi-
cations, and patients are reluctant to report non-adherence.
There are several approaches for improving medication adher-
ence assessment. One is to screen for missed appointments, as
non-adherence to appointments is correlated with lower med-
ication adherence rates, and may be the first sign of dropping
out of care entirely.28 Assessing non-adherence requires non-
judgmental communication. A key validated question is,
BHave you missed any pills in the past week?^, and any
indication of having missed one or more pills signals subop-
timal adherence requiring further exploration.29 Compared
with pill counts, asking non-responders about their medication
adherence using this single question will detect 55 % of those
with less than 100 % adherence.30 Another common assess-
ment question which incorporates motivational interviewing
and is generally more patient-centered is, BA lot of people find
it difficult to take their pills 100 % of the time. Tell me about
your experience in the last week.^ Suboptimal adherence can
be detected through review of fill dates and pill counts (asking
patients to bring in their medication bottles is a good idea
anyway). Another approach is to ask patients at what time
during the day they take their medications and how they
remember to do so (Clinical Scenario 2).
CLINICAL SCENARIO 2. EVALUATION OF
APPROPRIATE MEDICATION USE
Mrs. K. returns to the clinic 4 weeks later. Her back pain has
improved and she reports sleeping better at night. She is
meeting with her clergy, and her depression is improving.
Her blood pressure, however, remains above 150/100 mm
Hg. You ask about her medications, and she shares that she
has also been taking an anti-hypertensive medication Btwice a
day,^ in addition to the two diabetes medications she indicated
in the first encounter. You ask her for clarification regarding
what twice a day means for her; she shares that she takes both
hypertension medications—in the morning (four pills in the
morning). You acknowledge that this is one way to interpret
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what Btwice a day^ may mean, but you clarify that you would
like her to take each hypertension medication two times each
day, 12 h apart. You provide a schematic that highlights she
should take each medication once in the morning and once in
the evening. By engaging in a 2-min dialogue, you have
uncovered a fundamental misunderstanding of her drug
regimen.
MOTIVATIONAL INTERVIEWING AND COUNSELING
Motivational interviewing (MI) is a method for improving
communication around medication adherence.31. MI is a col-
laborative, person-centered form of counseling to elicit and
strengthen motivation for change by using open-ended ques-
tions, affirmative statements, and summarizing. Originally
developed as a counseling method for substance abuse, MI
was later expanded to behaviors associated with other ill-
nesses.32–36 An example of an MI question technique may
include, BWhat would be some ideas that may help you
remember to take your hypertension medication?^ MI is
intended to help patients recognize and address their problems
and enhance their perception of autonomy and treatment
efficacy.34
MI has been shown to improve patients’ general health
status or well-being, promote physical activity, help develop
healthier nutritional habits, and manage chronic conditions
such as mental illness, hypertension, hypercholesterolemia,
obesity, and diabetes.37–41 Randomized controlled trials have
shown that brief MI training for clinicians is effective for
improving patient medication adherence, especially if there
is follow-up contact after an initial training,42,43 and even at
low doses (i.e., two or three sessions). MI is effective as a
pretreatment adjunct and as an approach for less motivated or
prepared patients, and may be applied for a wide range of
medications across diverse populations.11,44
Another communication technique that promotes patient-
centeredness and helps guide medication-related discussions
is a theory-based counseling model called the 5 A’s. This
model has been shown to be suitable for application in busy
healthcare environments and does not require sophisticated
skills or experience.45 The 5 A’s include the following steps:
1) assess beliefs, behavior, and knowledge about their medi-
cation; 2) advise medication behavior change; 3) agree upon
clear goals for medication use; 4) assist in addressing barriers
and securing social support; and 5) arrange follow-up con-
tact.46 Use of the 5 A’s is associated with change in health
behaviors across diverse populations and health behaviors.47–
49 Because the 5 A’s model covers the key elements of self-
management support, it presents a guiding conceptual frame-
work for evaluating and implementing behavioral change
counseling interventions in chronic disease management
(Clinical Scenario 3).50 Thus, this framework could be easily
adapted to facilitate a person-centered approach to address
medication adherence.
CLINICAL SCENARIO 3. INCORPORATING ASPECTS
OF MOTIVATIONAL INTERVIEWING AND USE OF
5A’S45
At her next visit, Mrs. K. again complains of back stiffness and
not sleeping well. While these are the twomost pressing issues
from her perspective, you remain concerned about her hyper-
tension. You provide new suggestions for relieving stiffness
and discuss how increasing her physical activity may help
with her pain, sleep, and blood pressure. You also will remain
vigilant regarding her mood and previously reported symp-
toms of depression, as they may be related and may have an
impact on her ability to follow a treatment plan. Mrs. K.
indicates that she is open to trying some exercise—taking
her dog for a walk in the morning. However, she is concerned
that sometimes she is stiff in the morning. You explore barriers
and facilitators that may impact her exercising and ask how
confident she is that she can start out slowly and gradually
increase her walking. You ask Mrs. K. to keep track of her
weekly exercise and to try to walk every other day for a
minimum of 15 min. She agrees to contact you in 4 weeks
regarding her exercise regimen and pain level.
You also assess Mrs. K.’s beliefs and barriers regarding the
use of her anti-hypertensive medication.When you ask, BHave
you missed any pills in the past week?^, she indicates that she
sometimes forgets to take her blood pressure medications and
does not take them when she feels stressed. You review with
Mrs. K. that high blood pressure is asymptomatic and that the
medications work best when taken around the same time each
day, and ask whether she has had any adverse effects with her
blood pressure medications. If she experiences side effects,
such as dizziness, you share with her what to do. You sum-
marize the visit by saying that, with the goal of increasing her
activity and taking her two blood pressure medications daily,
you expect her pain to decrease and her blood pressure to
improve. Mrs. K. will measure her blood pressure at home
every other day for the next 4 weeks, and at the next visit you
will reasses both her pain and blood pressure control.
To help remind her to take her medications, you askMrs. K.
to name an activity that she does twice a day. Mrs. K. indicates
that she brushes her teeth twice daily and that she will place
her anti-hypertensive medication near her toothbrush.
SHARED DECISION-MAKING TO OPTIMIZE MEDICA-
TION USE
Research studies have examined shared decision-making
(SDM) for a variety of illnesses and disabilities, including
treatment decisions related to cancer51, mental illness52, and
substance abuse.53 Results have demonstrated that SDM leads
to enhanced patient knowledge and patient satisfaction with
treatment choices (Clinical Scenario 4).21,54,55 However, in
studies that have examined actual provider–patient interac-
tions, researchers found that healthcare professionals almost
always fail to adequately educate patients and enlist them in a
95Bosworth et al.: Person-Centered Approaches to AssessingJGIM
process that meets the criteria for fully informed decision-
making.56,57 In a study of fully insured individuals, after adjust-
ing for potential confounders including health literacy and
education, patients’ perceived lack of SDM was significantly
associated with primary medication non-adherence (i.e., not
filling a new prescription; RR = 2.42, p < 0.05), early non-
persistence (RR = 1.34, p < 0.01), and new prescription medi-
cation gap (5 % greater gap in medication supply, p < 0.01).58
The benefits of SDM include incorporating evidence and
patient preferences into a consultation; improving patient
knowledge, risk perception accuracy, and patient-clinician
communication; and reducing decisional conflict, feeling un-
informed, and inappropriate use of tests and treatments.59
SDM frames health decisions as an exchange between patient
and healthcare provider with key components.53,60 Compo-
nents of SDM include joint identification of the advantages
and disadvantages of a specific issue by the patient and pro-
vider, and the provision of education about the illness and
corresponding treatments. Thus, SDM is a process in which
patients can express their preferences and goals, and reach an
agreement with their provider regarding the treatment deci-
sion.61 MI and SDM are complementary approaches.
SDM is not a single step within a consultation, but rather a
social exchange that utilizes counseling skills to enhance
engagement and guide decisions about treatments. Elements
of SDM that providers employ include defining and explain-
ing the problem; presenting options; discussing pros and cons
(e.g., benefits, risks, costs); ascertaining a patient’s values and
preferences; exploring the patient’s self-efficacy; offering rec-
ommendations; checking and clarifying patient understand-
ing; moving or deferring a decision, if needed; and arranging
follow-up.53,60 Various channels have been used to supple-
ment this information exchange beyond direct patient-
provider interactions, with Internet applications (e.g., SDM
aids or tools) and social networks being especially promising
innovations.62 While this may be difficult to accomplish in a
typical clinical encounter, decision aids can be accessed out-
side of the clinical encounter, and additional support from the
provider team may need to be considered.
SDM is a key element of successful medication adherence,
but the prospect of long conversations may be daunting to
providers with limited time per visit. However, as pointed out
in a recent paper examining the 12 common myths of SDM,63
it does not necessarily result in more time per consultation. In
fact, a 2014 Cochrane review analyzed 115 decision aids,64
and among the ten papers that measured consultation length,
two found that SDM took longer, one found that it took less
time, and six found no statistically significant difference in
consultation time.64 Furthermore, training physicians in com-
munication skills results in substantial and significant
improvements in patient adherence; one study showed that
the odds of patient adherence were 1.62 times higher with
physician communication training than without.65 The princi-
ple of reaching common ground may allow providers to use
their time with patients more efficiently.
SDM usually occurs within the physician–patient dyad;
however, there are several advantages to engaging interpro-
fessional teams (e.g., including different members of the
healthcare system) in SDM. Interdisciplinary teams may con-
tribute different knowledge and skills to the decision-making
process, thus producing more feasible and sustainable deci-
sions.65 From the patient’s standpoint, an interprofessional
(IP) approach to SDM may increase the likelihood of patient
participation in decision-making and support agreement re-
garding a healthcare treatment.66,67 Such interventions could
also improve the decisions made by patients and their health-
care teams by fostering integrated healthcare services and
continuity of care68, and as a result, they could better match
what patients request to what they receive. A Cochrane review
suggests that practice-based IP collaborative interventions can
improve healthcare processes and outcomes.69
CLINICAL SCENARIO 4. SHARED DECISION-MAKING
You have already elicited from Mrs. K. that her primary
concern is her back pain, which makes looking for work
difficult. She remains depressed and describes financial hard-
ship in paying for her medications. You are concerned because
her blood pressure is running higher than when you saw her 6
months ago. You realize that your goal of blood pressure
control is not aligning with her concern regarding pain. You
tell her that you understand that the pain is her main problem,
but that you are still concerned about her blood pressure. You
ask her to recall your conversation at her last visit, and review
what she knows about high blood pressure. She says that she
remembers that it can lead to heart problems and stroke. You
acknowledge that she is correct and emphasize that treatment
prevents these problems; you ask whether she is willing to
address both problems at this time, and she agrees. Thus, you
prioritize addressing the back pain and develop a pain man-
agement plan. You ask her what barriers she sees to improving
her blood pressure. She says that her main concern is avoiding
the cost of adding another medication. You agree not to do so
and discuss trying to improve blood pressure control through
exercise. You have achieved agreement from Mrs. K. that her
higher blood pressure is a problem, and she agrees to try to cut
back on her salt intake and walk more in the morning. You
schedule a follow-up appointment in a month.
INTEGRATING MOTIVATIONAL INTERVIEWING AND
SHARED DECISION-MAKING
In a recent manuscript,70 Elwyn et al. present a model that
integrates the concepts of SDM and MI. Practitioners may
benefit from using both approaches to help individuals con-
sider options for medication management. MI and SDM are
inherently dependent on communications skills to develop
trust, understanding, and empathy, and to facilitate decision-
making and subsequent behavioral change. These aims are
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accomplished through reflective listening, sharing of informa-
tion, and responding to emotions.70
SPECIFIC ROLES OF THE PROVIDER AND HEALTH
SYSTEM IN SUPPORTING MEDICATION ADHERENCE
THROUGH PERSON-CENTERED APPROACHES
Healthcare providers have an important, yet largely unreal-
ized, opportunity to participate in a person-centered approach
to support their patients’ use of medications. A provider’s role
begins with an assessment of adherence for each patient.
Providers need to be familiar with risk factors for non-adher-
ence, as well as proven strategies to improve adherence and to
tailor interventions to individual patients’ needs.71 Some prac-
tical approaches include:
& Anticipating common patient misperceptions—for exam-
ple, that a medication for a chronic condition can be
stopped when the prescription runs out, or that medi-
cations should be taken only when symptoms arise
& Considering the cost of medications
& Minimizing the complexity of treatment regimens (once-
daily dosing and appropriate combination drugs)
& Reducing polypharmacy72
& Using positive reinforcement—providers should offer
congratulations if they find that the patient is following
the treatment plan
& Abandoning the notion that asking about common side
effects will cause the patient to start experiencing them;
patients are often reluctant to raise concerns about their
treatment unless asked, and side effects can be a
barrier73–75
The provider is central to achieving buy-in, keeping treat-
ment regimens simple and focused, and evaluating improve-
ment. The healthcare system also serves to support an envi-
ronment where all of the stakeholders can provide support
mechanisms to improve patient care, outcomes, and satisfac-
tion.76 Ultimately, the healthcare system needs to support the
patient and provider team across the continuum of care. For
example, helpful interventions for patients with low health
literacy include designing and offering easy-to-understand
health educational materials and chronic disease management
programs, improving medication drug labeling, and offering
and incentivizing communication training for clinicians.77
THE ROLE OF HEALTH TEAMS IN OPTIMAL
MEDICATION USE
Findings from a recent review suggest that adherence inter-
ventions using a team approach are effective in improving
cardiovascular medication adherence,78 with a growing body
of literature supporting a nurse/physician79 or pharmacist/phy-
sician79,80 team approach. The essential feature of the patient-
centered medical home (PCMH) is retaining the primacy of an
ongoing relationship between patients and their primary care
providers, although this relationship has been expanded to
include other members of a core team (e.g., clerks, nurses)
with whom the patient and provider have an ongoing relation-
ship. Additional providers including dieticians and other clin-
ical support staff can complete the team, depending on the
patient’s needs. The approach is proactive, both in rigorously
assessing risk factors and health issues and in addressing those
that are known.81 One goal of the PCMH model is to remove
barriers (e.g., physical, temporal, financial) between the pa-
tient and healthcare team. This requires an open-scheduling
system, an electronic health record that supports communica-
tion between team members and the patient, delegation of
tasks among team members, enhanced use of non-face-to-
face care, and integration of clinical data. When implemented
well, PCMH can improve quality of care and patient and
provider satisfaction.81,82
PUTTING IT ALL TOGETHER: PERSON-CENTERED
APPROACHES TO APPROPRIATE MEDICATION USE
Using a case study, we have highlighted person-centered
approaches for evaluating and supporting medication adher-
ence. Underlying this process is fundamental communication
between the patient and provider. Aspects of this person-
centered approach include agreeing on the problem(s) and
prioritizing. In this case study, it would have been challenging
to focus solely on poor blood pressure control without con-
sidering the competing problems of pain and depression and
related barriers to blood pressure control. Once the provider
and individual agree on the issue, diagnosis, and treatment,
setting attainable goals should occur.
Generating options. is often a helpful method. There is more
than one diet for losing weight, and there is more than one
drug to treat hypertension. Acknowledging this fact gives the
patient an opportunity to be involved in his or her care. This
includes reviewing a reasonable range of treatment options,
discussing the benefits and possible side effects of each in
terms the patient can understand, and then asking the patient
what he/she thinks might work.
Decide on a mutually agreeable and measurable regimen.
Provider and patient can choose a medical option that makes
sense in the patient’s life. For example, the patient with
hypertension may have just remarried and does not want a
low-cost drug that could reduce sexual drive. She may opt for
a high-cost product with no sexual side effects. Dosage fre-
quency requires a similar discussion. Once-a-day drugs can
improve adherence because they simplify dosage; however,
they could discourage low-income patients from filling their
prescriptions if they are more expensive than a multiple-dose
version of the same agent. Some may be better off with a less
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expensive, three-times-a-day version. In many instances, ad-
herence hinges both on the patient and on his or her family.
Understand a patient’s knowledge. Consider having the
patient repeat what they have been told about their illness
and treatment plan. You can say, BTell me what you
understand about your illness.^ Likewise, ask them to
explain their treatment plan, just as if they were talking to
their spouse. It is also important for patients to demonstrate
any techniques they have been taught, such as injecting insulin
or using a peak flow meter.
Screen for readiness.One may consider two final questions at
the end of an encounter to ensure that the patient’s goals and
values are addressed. The first is, BHow important do you
think it is for you to do the things we’ve been talking about?^
The provider might discover, for example, that Mrs. K. is
convinced that her disease will kill her as it did her mother,
and that any treatment is futile. The provider will need to talk
more about the disease and its management if a belief of this
type surfaces. Another question to consider is, BOn a scale of 1
to 10, how confident are you that you can adhere to this
treatment regimen?^ Mrs. K., who is absolutely convinced
that her hypertension medication does not work, may have a
confidence level of 1 that she can actually do so, thus
indicating that more counseling and support may be needed
(Clinical Scenario 4).
CLINICAL SCENARIO 5. RESOLUTION
After answering her questions, you ask Mrs. K. to repeat the
information back to you. In addition, you ask whether you
may explain the regimen to her husband/other family member/
caregiver. Finally, you provide a written reminder with pic-
tures describing when each medication should be taken and
suggest she display this at home as another tool to serve as a
reminder. You ask her to explain what the recommended
regimen is and ask her how confident she is with maintaining
her treatment regimen.
For the next 2 weeks a clinic nurse will call Mrs. K. once a
week to determine whether she is taking the right medications
at the right time and to check on her home blood pressure
values. Mrs. K. is encouraged to contact the clinic with any
questions or concerns.
In summary, given the continued problems of medication
adherence and associated costs and the complexity of the
problem, further thought and attention to person-centered
approaches are needed. Often our clinical priority may not
be as important to the patient as social, psychological, or other
clinical comorbidities that need to be addressed and reconciled
within an overall treatment plan. We provide recommenda-
tions for how healthcare providers and teams can improve
health communication by employing clear person-centered
communication techniques that confirm and reinforce patient
understanding and seek to improve medication adherence.
Recommendations for Providers on Person-Centered
Approaches to Assess and Improve Medication Adherence
Provider
• Clarify objectives of therapy
• Ensure that the patient’s decision reflects their goals and preferences
• Screen for missed appointments
• Engage the patient and ask them to describe their medication regimen,
such as when they take their medication and what the medication is for
• Use of communication skills (e.g., motivational interviewing, 5 A’s
model)
• Define and explain the problem
• Present options
• Discuss pros and cons (e.g., benefits, risks, costs)
• Elicit information regarding patient’s values and preferences
Examine individual’s readiness to change
• Explore patient’s self-efficacy
• Anticipate and avoid common patient misperceptions
• Offer recommendations
• Check and clarify patient understanding
• Move or defer a decision, if needed, and arrange follow-up
Patient
• Understand knowledge, beliefs, and attitudes about treatment
• Determine ability to attain therapeutic goals
• Ask providers to explain the therapeutic options in order to make
decisions concordant with goals and preferences
• Articulate personal goals and preferences
• Set and manage expectations of the treatment plan
Healthcare system
• Support for training in motivational interviewing, and shared decision-
making
• Provide evidence-based shared decision-making support tools
• Use information technology to help educate and support their patients
• Support the patient and provider team across the continuum of care
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